Polymorphism versus devitrification mechanism: Low-wavenumber Raman investigations in sulindac

Int J Pharm. 2019 Aug 15:567:118476. doi: 10.1016/j.ijpharm.2019.118476. Epub 2019 Jun 27.

Abstract

The polymorphism of sulindac was investigated by Raman investigations, mainly in the low-wavenumber region in order to analyze the influence of the amorphization method on recrystallization and crystalline form stability. By devitrification of the quenched liquid, it was found that the undercooled liquid crystallizes into Form I, and a polymorphic transformation by cooling Form I toward Form IV, was clearly revealed. The low-wavenumber spectra of polymorphic forms are direct fingerprints of crystals, indicating a degree of disorder of Form IV intermediate between those of the ordered Form II (commercial form) and the relatively disordered Form I. This study has shown the enantiotropic relationship between Forms I and IV and that both the temperature of crystallization and the physical stability of Form I prepared is dependent on the technique used for preparing amorphous sulindac.

Keywords: Active pharmaceutical ingredient; Amorphous; Devitrification mechanism; Low-wavenumber Raman spectroscopy; Polymorphism.

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / chemistry*
  • Crystallization
  • Spectrum Analysis, Raman
  • Sulindac / chemistry*
  • Vitrification

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Sulindac